Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > alba... did you make money with ico?

<< Previous

Bullboard Posts

Next >>

Comment by Alba1314on Jan 21, 2021 8:46am

199 Views

Post# 32343009

RE:alba... did you make money with ico?

You sold and lost money. Move on. Why waste your time ranting and raving about it and spreading lies? I can't hold your hand through this, but there is some new potential for this stock that makes it worth a second look. Still high risk. A junior mining company would be safer

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks